Cite

HARVARD Citation

    Hallmeyer, S. et al. (2023). Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing. Biology methods & protocols. 8 (1), p. . [Online]. 
  
Back to record